Biotinylated Human PD-L1, Fc,Avitag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized Human PD-1, Fc Tag, low endotoxin (HPLC-verified) at 2 ug/mL (100 uL/well) can bind Biotinylated Human PD-L1, Fc,Avitag,His Tag with a linear range of 2-39 ng/mL.
Immobilized Human B7-1, mouse IgG2a Fc Tag, low endotoxin at 5 ug/mL (100 uL/well) can bind Biotinylated Human PD-L1, Fc,Avitag,His Tag with a linear range of 0.02-0.625 ug/mL.
Serial dilutions of nivolumab were added into Human PD-1, Fc Tag, low endotoxin (HPLC-verified): Biotinylated Human PD-L1, Fc,Avitag,His Tag binding reactions. The half maximal inhibitory concentration (IC50) is 0.5381 ug/mL.
Flow Cytometry assay shows that Biotinylated Human PD-L1, Fc,Avitag,His Tag can bind to 293 cell overexpressing human PD-1. The concentration of PD-L1 used is 1 ug/mL.
FACS analysis shows that the binding of Biotinylated Human PD-L1, Fc,Avitag,His Tag to 293 overexpressing PD-1 was inhibited by increasing concentration of neutralizing anti-PD-1 antibody. The concentration of PD-L1 used is 2 ug/mL. The IC50 is 0.64 ug/mL.
Immobilized cell surface PD-1 (5x104 of cells per well) can bind Biotinylated Human PD-L1, Fc,Avitag,His Tag with an EC50 of 0.082 ug/mL.